Barclays raised the firm’s price target on Humana (HUM) to $322 from $270 and keeps an Equal Weight rating on the shares. The firm revised up its “bull and bear” earnings estimates after assessing next year’s stars contract risk.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM: